|
urriculum Vitae
Academic Rank and Position
Retired Brigadier
General from the Jordanian Royal Medical Services.
X-Chief of
Hematology/Oncology & Bone Marrow Transplantation
Department of
Internal Medicine,
King Hussein Medical
Center
Private Practice 2009
Education
College: La College De la Sale / Amman-Jordan 1963-6/1975.
Pre-Medicine / University of Jordan 7/1975-6/1977
Medical School / University of Jordan MB, BS. 7/1977-6/1982
Internship; Al-Bashir government hospital 7/1982-6/1983
Military training 7/1983-11/1983
Army Medical Officer 12/1983-12/1984
Residency in Internal Medicine / Royal Medical Services
Residency 1/1/1985-31/12/1988.
Sabbatical in the United Kingdom 1/1/1989-12/31/1989;
Whittington Hospital/London advanced internal medicine course
National Hospital for Nervous diseases/ London
1/1/1994-12/31/1995
Fellowship in
Hematology/Oncology: Jordanian Royal Medical Services 12/31/1995-
7/1/1997
Fellowship in
Hematology/Oncology: Medical College of Wisconsin/USA 7/1/97-
30/6/2000.
Fellowship from the American College of Physicians June 2000.
Board Certification
Boarded in Internal Medicine
National Boards United States Medical Licensure Exam; I, II,
III
Boarded in Hematology and Medical Oncology
Medical Licensure &
Certificates
Jordan Medical Association 1983
ECFMG certificate 1984
Diploma advanced medicine, University of London 1989
Postgraduate
fellowship in neurology; National hospital for
Nervous diseases 1989
Wisconsin State Medical License/USA # 40824
American Drug Enforcement Administration (DEA) License #
BA6315483
Fellowship in Hematology/Oncology Medical College of
Wisconsin 2000.
Fellowship of the American College of Physicians (FACP) 2000.
Honors and Awards
Medal
of Bravery, the Jordanian army 1994
Oncology Fellowship Award from RPR for 1999
Physician’s Recognition Award Certificate from AMA 2000
Medal
of Long and Loyal Service, the Jordanian army 2001
Winner of the International Fellowship Award offered by the
American College of Physicians 2005
Military Services
Retired Brigadier
General from the Jordanian Royal Medical Services.
Previous Professional
Positions and Appointments
Princess Haya Hospital/Aqaba–Jordan (Head of internal Medicine)
1/1/1990 – 12/31/1991
Prince Zeid Hospital/Tafila-Jordan (Head of internal Medicine)
1/1/1994-12/31/1995.
Queen Alia Hospital
1/11992- 12/31/1992 (Member of the Mortality Morbidity Committee).
Princess Haya Hospital/Aqaba–Jordan (Head of internal Medicine)
1/1/1990 – 12/31/1991
Queen Alia Hospital/Amman-Jordan (Internal Medicine
Specialist)
1/1/1992-12/31/1992
Prince Hashem Hospital/Zarka-Jordan (Internal Medicine
Specialist)
1/1/1993-12/31/1993
Prince Zeid Hospital / Tafila-Jordan (Head of internal Medicine)
King Hussein Medical Center-Amman
Chief of Hematology/Oncology
& BMT Unit.
Attending Oncologist at King Abdalla Hospital-Irbid
Private practice September/01/08
Education-Teaching
Clinical Instructor
at the University of Jordan and King Hussein Medical Center
1995-1997.
Member of morbidity mortality committee at Queen Alia
Hospital 1993.
Seminar moderator at King Hussein medical Center 1995-1997.
Teaching Medical
students at the Medical College of Wisconsin. 1997-2000.
Teaching Residents at
King Hussein Medical Center.
Principle Investigator
High-Dose
cyclophosphamide without stem cell rescue for the treatment of
severe autoimmune diseases. (Protocol at the Medical College of
Wisconsin).
Waldenstörm
macroglobulinemia protocol for patients undergoing autologous bone
marrow transplantation. (Protocol at the Medical College of
Wisconsin).
High-Dose
Chemotherapy for patients with Primary Systemic Amyloidosis. (IBMTR
study).
Professional and Society
Memberships
Jordan Medical Association 1982
Jordanian Internal Medicine Association 1988
American College of Physicians 1995
American Society of Clinical Oncology 1997
American Medical Association 1997
Wisconsin State Medical Society 1997
American Society of Hematology 1998
European Group for Blood and Marrow Transplantation
2003
Senologic International Society 2007
Presentations at
International Meetings
1- Third
international symposium on Bone Marrow Transplantation in
Thalassemia; Pesaro, Italy September 29, 1996. “Jordanian experience
in Thalassemia. Bone Marrow Transplantation”.
2- First
international medical congress of the Royal Medical Services May,
1996. “Philadelphia Positive AML, Biological characteristics and
treatment outcome” Holiday-Inn Amman.
3- First
International Medical Congress of the Royal Medical Services May 17,
1996. “Testicular germ cell tumor at (KHMC) ”. Holiday Inn Amman.
4- First
International Medical Congress of the Royal Medical Services May15,
1996. “Plasma lipid profile in a Jordanian population”. Holiday Inn
Amman.
5- First
international medical congress of the Royal Medical Services May,
1996. “Familial Mediterranean fever in Jordanians”.
Holiday Inn Amman.
6- American Society
of Hematology Forty-First Annual meeting December
1999 New Orleans LA,
USA. M. Akasheh, M Abu-Hajir. The safety of Enoxaparin in patients
older than 60 years with Non-APL AML or high risk MDS undergoing
induction or consolidation chemotherapy. Blood. (Supplement)
November 1999, abstract [4211].
7- 2000 Tandem BMT
Meetings Anheim, California. March 27, 2000. Study #MM98-02
Development of Disease-Specific data collection form for Waldenstorm
Macroglobulinemia.
8- The 2000 Tandem
BMT Meetings Anheim, California. March 27, 2000. Study# MM00-01
Principle Investigator: High-Dose Therapy for patients with Primary
Systemic Amyloidosis.
9- American Society
of Hematology December 2000 San Francisco, California. Engraftment
syndrome after autologous hematopoietic stem cell transplantation
supported by granulocyte colony-stimulating factor or
granulocyte-macrophage colony-stimulating factor.
10- American Society
of Hematology December 2000 San Francisco, CA.
Melphalan associated
pulmonary toxicity following high-dose therapy with autologous
hematopoietic stem cell transplantation.
12- American Society
of Clinical Oncology meeting May 2001 San Francisco, CA. Routine
liver imaging is unnecessary in the work-up of T1-2 N0-1 breast
cancer.
13- The First
International Medical Conference November 2001 King Hussein Medical
Center; Amman. The first 60 cases of Hematopoietic Stem Cell
Transplantation.
14- The Third
Jordanian Oncology Conference September 2001, Amman. Myelodysplastic
Syndrome: A review from King Hussein Medical Center.
15- The 2002 Meeting
of the European Group for Blood and Marrow Transplantation
Montreaux, Switzerland. The effect of religious faith and Family
support on the quality of life of patients undergoing Hematopoietic
Stem Cell Transplantation (Poster).
16- The 2002; 27th
European Society of Clinical Oncology Congress: Nice, France. Phase
I/II study of multiple cycles of high-dose iv melphalan for elderly
patients with multiple myeloma without stem cell rescue (Poster).
17- The Second
International Medical Conference of the Royal Medical Services:
Amman. Routine Liver Imaging is Unnecessary in T1-2 N0-1 Breast
Cancer.
18- American Society
of Hematology annual meeting December 2003 San Diego, CA. David
Vesole, Waleska Perez, D. E. Reece, Marwan Akasheh, M
Horowitz. High-dose therapy with Autologous Hematopoietic Stem Cell
Transplantation for patients with primary systemic amyloidosis (AL):
results from the autologous blood and marrow transplant registry
(ABMTR).
19- Future of
Surgical Training 23-25 August 2007. Local
Perspectives in Gastric Cancer Therapy. Amman-Jordan Radisson
Hotel
Continuous Medical Education credit
American Society of
Clinical Oncology meeting in L.A. May 1998.
Southeastern
Wisconsin Cancer Conference Milwaukee WI. April 1998-4 credit hours.
Educational fall
meeting of the American Society of Clinical Oncology in IL. Nov.
1998-8.5 credit hours.
American Society of
Hematology meeting in Miami, FL. Dec.1998.
American Society of
Clinical Oncology meeting in Atlanta, GA. May 1999-10.75 hours.
ACP-ASIM Wisconsin
Chapter Milwaukee, WI. Sept. 1999.
American Society of
Hematology meeting New Orleans, LA 1999-14 credit hours.
ACP-ASIM annual
meeting in Philadelphia, PA 2000-18 credit hours,
MKSAP Hematology
1999-50 credit hours
MKSAP 11 1999-144
credit hours
Tandem Bone Marrow
Transplant meeting; Anheim, CA 2000.
COMO (Congress
Oriental Medical Oncology) April 2001, Beirut-Lebanon.
European Bone Marrow
Transplant Meeting: Montreux-Switzerland March, 2002.
European Society of
Medical Oncology 28th Meeting, Nice-France October 2002.
The European Cancer
Conference Copenhagen 12: Copenhagen-Denmark September 2003.
European Society of
Medical Oncology 29th Meeting, Vienna: Austria October
29, 2004.
1st
Novartis Middle East & Africa Oncology Summit January 2005
Dubai.
American College of
Physicians Annual meeting Philadelphia April, 2006
European Bone Marrow
Transplant Meeting; Hamburg-Germany March, 2006
The European Society
of Urology annual meeting:Amsterdam June 2006
Lebanese Society of
Medical Oncology. Best of ASCO November 17-18, 2006 Lebanon
European Society of
Medical Oncology 32 Meeting, Barcelona: Spain September15, 2007.
Pfizer Principle
Investigator meeting on Sutent: Paris August 15,2008
European Society of
Medical Oncology 33 Meeting, Stockholm: Sweden September 13, 2008.
GRANTS
Winner of the
Fellowship Exchange Program Award 2004 Sponsored by the American
College of Physicians.
PUBLICATIONS
1.
Akasheh MS. Graves’ disease mimicking
B-thalassemia trait. Postgrad Med J 1994; 70:300-1.
2.
Akasheh MS. Still Hazy after all these
years. N Eng J Med 1995; 332:332-3.
3.
Akasheh MS, et al Rapidly
progressive renal failure complicating acute rheumatic fever.
Postgrad Med J 1995; 71:553-4.
4.
A. Najada, MS Akasheh, et al
Congenital afibrinogenemia and familial combined hyperlipidemia in a
kindred. Bahrain Medical Bulletin 1996; 8(4):133-6.
5.
M. Karadsheh, MS Akasheh, et al Plasma
lipid profile in the male population of the Jordanian armed forces.
Bahrain Medical Bulletin 1996; 18(3):89-91.
6.
M. Akasheh, K Omari, F Madanat. Skin
rash in a jaundiced patient. Postgrad Med J 1997;73: 677-8.
7.
K. Omari, M Akasheh, et al. Jordanian experience in Thalassemia. Bone
Marrow Transplantation 1997, March (supplement):94-5.
8.
MS Akasheh et al. Pseudomyxoma peritonei. The Practitioner No.2.1998
9.
F.Madanat, M Akasheh. HELLP Syndrome
with ruptured liver. The Practitioner 1998, April; 6 :116-9.
10.
Marwan Akasheh. A case of central
nervous system chloroma. Grand Rounds Publication. Medical College
of WI. Volt 5, No 4. Sept. 1998.
11.
Marwan Akasheh, David Vesole. Bloody
diarrhea in a bone marrow transplant recipient. Grand Rounds
Publication. Vol5, No 4. Sept. 1998.
12.
MS
Akasheh et al. Accelerated atherosclerosis in a patient with post
BMT-Nephropathy. Bone Marrow Transplantation 1999; 22:199-201.
13.
MS Akasheh, D. Vesole. Acute Tumor
Lysis; A case in AL-Amyloidosis. British J Haematology 1999;107:
386-387.
14.
M Akasheh, C Freytes, D Vesole.
Melphalan associated pulmonary toxicity following high-dose therapy
with autologous hematopoietic stem cell transplantation. Bone
Marrow Transplantation 2000; 26:1107-9.
15.
M Akasheh, M Abu-Hajir. The safety of
Enoxaparin in patients older than 60 years with Non-APL AML or high
risk MDS undergoing induction or consolidation chemotherapy.
Blood. (Supplement) November 1999, abstract [4211].
16.
M. Akasheh, M. Abu-Hajir. The safety
of Enoxaparin in patients older than 60 years with Non-APL AML or
high risk MDS undergoing induction or consolidation chemotherapy.
Thrombosis in Oncology, December 2000.
17.
M Akasheh, F Mdanat, A Telfah et al.
Routine liver imaging is unnecessary in the work-up of T1-2 N0-1
breast cancer. ASCO Proceedings, May 2001.
18.
M Akasheh. Myeloblastoma of the
central nervous system. Journal of the Royal Medical Services,
December 2001.
19. K Omari, M Akasheh, et al.
The effect of religious faith and Family support on the quality of
life of patients undergoing Hematopoietic Stem Cell Transplantation
(Poster). Meeting of the European Group for Blood and Marrow
Transplantation Montreaux, Switzerland. Bone Marrow Transplantation
Vol 29, Supplement 2 March 2002.
20.
M Akasheh, A Telfah. Routine liver imaging is unnecessary in the
work-up of T1-2 N0-1 breast cancer. Annal Saudi Med. Vol 22, No.
3-4. July 2002.
21.
K Omari, M Akasheh, et
al. Phase I/II study of multiple cycles of high-dose iv melphalan
for elderly patients with multiple myeloma without stem cell rescue
(Poster). Annals of Oncology Vol 13, Supplement (5) 2002.
21. M Akasheh,
MAbu-hajir. The safety of enoxaparin in patients older than 60 years
with acute myelogenous leukemia or high risk myelodysplastic
syndrome undergoing chemotherapy. Bahrain Medical Bulletin, Vol. 24,
No.2, June 2002
22.
M Akasheh, D Eastwood, D H Vesole. Engraftment syndrome after
autologous hematopoietic stem cell transplant supported by
granulocyte-colony stimulating factor (G-CSF) versus granulocyte
macrophage-colony stimulating factor (GM-CSF). Bone Marrow
Transplantation 2003; 31: 113-7.
23. David Vesole, Waleska Perez, D. E. Reece, Marwan Akasheh,
M Horowitz. High-dose therapy with Autologous Hematopoietic Stem
Cell Transplantation for patients with primary systemic amyloidosis
(AL): results from the autologous blood and marrow transplant
registry (ABMTR).
Blood (Supplement) November 16 2004, [abstract].
|
24. D Vesole, W Perez, M Akasheh et al. High Dose Therapy
and Autologous Hematopoietic Stem CellTransplantation (HSCT)
for Patients With Primary Systemic Amyloidos(AL): A CIBMRT
Study. Mayo Clinic Proceedings 2006;81 (7):880-888.
|
|
